NO20015374L - Nye forbindelser - Google Patents
Nye forbindelserInfo
- Publication number
- NO20015374L NO20015374L NO20015374A NO20015374A NO20015374L NO 20015374 L NO20015374 L NO 20015374L NO 20015374 A NO20015374 A NO 20015374A NO 20015374 A NO20015374 A NO 20015374A NO 20015374 L NO20015374 L NO 20015374L
- Authority
- NO
- Norway
- Prior art keywords
- new connections
- connections
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/09—Diamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901572A SE9901572D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
| PCT/SE2000/000846 WO2000066550A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20015374L true NO20015374L (no) | 2001-11-02 |
| NO20015374D0 NO20015374D0 (no) | 2001-11-02 |
Family
ID=20415425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20015374A NO20015374D0 (no) | 1999-05-03 | 2001-11-02 | Nye forbindelser |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7354895B1 (ro) |
| EP (1) | EP1180099A1 (ro) |
| JP (1) | JP4270759B2 (ro) |
| KR (1) | KR20020010631A (ro) |
| CN (1) | CN1358187A (ro) |
| AR (1) | AR028826A1 (ro) |
| AU (1) | AU4447100A (ro) |
| BR (1) | BR0010256A (ro) |
| CA (1) | CA2371215A1 (ro) |
| CZ (1) | CZ20013931A3 (ro) |
| EE (1) | EE200100573A (ro) |
| HK (1) | HK1042493A1 (ro) |
| HU (1) | HUP0202379A3 (ro) |
| IL (1) | IL145953A0 (ro) |
| IS (1) | IS6141A (ro) |
| MX (1) | MXPA01011043A (ro) |
| NO (1) | NO20015374D0 (ro) |
| PL (1) | PL356140A1 (ro) |
| SE (1) | SE9901572D0 (ro) |
| SK (1) | SK15662001A3 (ro) |
| TR (1) | TR200103144T2 (ro) |
| WO (1) | WO2000066550A1 (ro) |
| ZA (2) | ZA200108967B (ro) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE239741T1 (de) * | 1999-09-14 | 2003-05-15 | Meiji Seika Kaisha | Derivate der phosphonsäure zur inhibierung von carboxypeptidase b |
| PT1311488E (pt) * | 2000-08-17 | 2009-12-30 | Pfizer Ltd | Imidazóis substituídos utilizados como inibidores de tafia |
| SE0103272D0 (sv) | 2001-09-28 | 2001-09-28 | Astrazeneca Ab | Chemical compounds |
| US6713496B2 (en) | 2002-01-22 | 2004-03-30 | Pfizer Inc | 3-(imidazolyl)-2-alkoxypropanoic acids |
| BR0307033A (pt) | 2002-01-22 | 2004-12-07 | Pfizer | ácidos 3-(imidazolil)-2-aminopropanóicos para o uso como inibidores tafi-a para o tratamento de doenças trombóticas |
| CN1620291A (zh) * | 2002-01-22 | 2005-05-25 | 美国辉瑞有限公司 | 作为tafia抑制剂的3－(咪唑基)－2－烷氧基丙酸 |
| CN1332964C (zh) | 2002-03-21 | 2007-08-22 | 舍林股份公司 | 血浆羧肽酶b抑制剂 |
| AU2009310841A1 (en) | 2008-10-29 | 2010-05-06 | Taisho Pharmaceutical Co., Ltd. | Compounds having TAFIa inhibitory activity |
| KR20210126044A (ko) * | 2019-02-08 | 2021-10-19 | 아스트라제네카 아베 | 아르기나제 저해제 및 이의 사용 방법 |
| CN111110837B (zh) * | 2020-01-06 | 2022-11-25 | 中国人民解放军陆军军医大学 | 一种羧肽酶抑制剂在制备预防重症致死性轮状病毒感染药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2516307A (en) * | 1949-01-06 | 1950-07-25 | Gen Mills Inc | Vinyl resins plasticized with cyano esters |
| US4560680A (en) * | 1982-03-15 | 1985-12-24 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
| US4849414A (en) * | 1986-06-11 | 1989-07-18 | E. R. Squibb & Sons, Inc. | Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors |
| FR2610951B1 (fr) * | 1987-02-17 | 1989-05-05 | Aerospatiale | Armature tissee pour materiau composite |
| IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
| SK74594A3 (en) * | 1991-12-17 | 1995-01-12 | Procter & Gamble Pharma | Treatment for treating of osteoporosis |
| US5550119A (en) * | 1995-03-02 | 1996-08-27 | Ciba-Geigy Corporation | Phosphono substituted tetrazole derivatives as ECE inhibitors |
| US5672592A (en) * | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
| JP3440305B2 (ja) * | 1997-04-02 | 2003-08-25 | 高砂香料工業株式会社 | ７−（ｎ−置換アミノ）−２−フェニルヘプタン酸 エステル誘導体及び該誘導体の製造方法 |
| EE04150B1 (et) | 1997-02-27 | 2003-10-15 | American Cyanamid Company | N-hüdroksü-2-(alküül-, arüül- või heteroarüülsulfanüül-, -sulfinüül- või -sulfonüül-)-3-asendatud -alküülamiidid, -arüülamiidid või -heteroarüülamiidid kui maatriksmetalloproteinaasi inhibiitorid |
| AR023819A1 (es) * | 1999-05-03 | 2002-09-04 | Astrazeneca Ab | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
| SE9901573D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
| ATE239741T1 (de) * | 1999-09-14 | 2003-05-15 | Meiji Seika Kaisha | Derivate der phosphonsäure zur inhibierung von carboxypeptidase b |
-
1999
- 1999-05-03 SE SE9901572A patent/SE9901572D0/xx unknown
-
2000
- 2000-04-28 AR ARP000102082A patent/AR028826A1/es not_active Application Discontinuation
- 2000-05-03 CA CA002371215A patent/CA2371215A1/en not_active Abandoned
- 2000-05-03 AU AU44471/00A patent/AU4447100A/en not_active Abandoned
- 2000-05-03 TR TR2001/03144T patent/TR200103144T2/xx unknown
- 2000-05-03 HU HU0202379A patent/HUP0202379A3/hu unknown
- 2000-05-03 EE EEP200100573A patent/EE200100573A/xx unknown
- 2000-05-03 CN CN00809484A patent/CN1358187A/zh active Pending
- 2000-05-03 CZ CZ20013931A patent/CZ20013931A3/cs unknown
- 2000-05-03 MX MXPA01011043A patent/MXPA01011043A/es unknown
- 2000-05-03 US US09/600,660 patent/US7354895B1/en not_active Expired - Fee Related
- 2000-05-03 IL IL14595300A patent/IL145953A0/xx unknown
- 2000-05-03 BR BR0010256-3A patent/BR0010256A/pt not_active Application Discontinuation
- 2000-05-03 KR KR1020017014014A patent/KR20020010631A/ko not_active Application Discontinuation
- 2000-05-03 EP EP00925844A patent/EP1180099A1/en not_active Ceased
- 2000-05-03 JP JP2000615381A patent/JP4270759B2/ja not_active Expired - Fee Related
- 2000-05-03 PL PL00356140A patent/PL356140A1/xx not_active Application Discontinuation
- 2000-05-03 SK SK1566-2001A patent/SK15662001A3/sk unknown
- 2000-05-03 WO PCT/SE2000/000846 patent/WO2000066550A1/en not_active Application Discontinuation
-
2001
- 2001-10-30 ZA ZA200108967A patent/ZA200108967B/en unknown
- 2001-10-30 ZA ZA200108966A patent/ZA200108966B/en unknown
- 2001-11-01 IS IS6141A patent/IS6141A/is unknown
- 2001-11-02 NO NO20015374A patent/NO20015374D0/no not_active Application Discontinuation
-
2002
- 2002-06-06 HK HK02104304.1A patent/HK1042493A1/zh unknown
-
2005
- 2005-12-02 US US11/293,060 patent/US7423012B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1180099A1 (en) | 2002-02-20 |
| IL145953A0 (en) | 2002-11-10 |
| US7423012B2 (en) | 2008-09-09 |
| US20060079484A1 (en) | 2006-04-13 |
| HUP0202379A3 (en) | 2003-04-28 |
| AU4447100A (en) | 2000-11-17 |
| JP4270759B2 (ja) | 2009-06-03 |
| TR200103144T2 (tr) | 2004-11-22 |
| JP2002543179A (ja) | 2002-12-17 |
| US7354895B1 (en) | 2008-04-08 |
| SK15662001A3 (sk) | 2002-09-10 |
| IS6141A (is) | 2001-11-01 |
| AR028826A1 (es) | 2003-05-28 |
| CA2371215A1 (en) | 2000-11-09 |
| SE9901572D0 (sv) | 1999-05-03 |
| CN1358187A (zh) | 2002-07-10 |
| WO2000066550A8 (en) | 2001-01-25 |
| BR0010256A (pt) | 2002-02-13 |
| NO20015374D0 (no) | 2001-11-02 |
| HUP0202379A2 (hu) | 2002-12-28 |
| MXPA01011043A (es) | 2002-06-04 |
| KR20020010631A (ko) | 2002-02-04 |
| EE200100573A (et) | 2003-02-17 |
| WO2000066550A1 (en) | 2000-11-09 |
| HK1042493A1 (zh) | 2002-08-16 |
| ZA200108967B (en) | 2003-01-30 |
| ZA200108966B (en) | 2003-01-30 |
| PL356140A1 (en) | 2004-06-14 |
| CZ20013931A3 (cs) | 2002-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20014518D0 (no) | Nye forbindelser | |
| DK1202994T3 (da) | Nye forbindelser | |
| NO20021436L (no) | Nye forbindelser | |
| NO20026064L (no) | Nye forbindelser | |
| NO20023933L (no) | Nye forbindelser | |
| NO20033715L (no) | Nye sammensetninger | |
| NO20016115D0 (no) | Substituerte heterocykelkondenserte gamma-karboliner | |
| NO20015383L (no) | Nye forbindelser | |
| NO20020810L (no) | Nye fenylpiperaziner | |
| NO20025151D0 (no) | Nye forbindelser | |
| DK1237857T3 (da) | Nye Phenalkyloxyphenylderivater | |
| NO20031141D0 (no) | Nye forbindelser | |
| NO20015074L (no) | Nye sammensetninger | |
| NO20010860D0 (no) | Nye forbindelser | |
| NO20010861D0 (no) | Nye forbindelser | |
| NO20026162D0 (no) | Nye forbindelser | |
| NO20026081D0 (no) | Nye forbindelser | |
| NO20030274L (no) | Nye aryleten-sulfonamider | |
| NO20015374D0 (no) | Nye forbindelser | |
| NO995945D0 (no) | Nye forbindelser | |
| NO20014629D0 (no) | Nye forbindelser | |
| NO20022927D0 (no) | Substituerte pyrrazoler | |
| NO20016273D0 (no) | Nye forbindelser | |
| NO20010584D0 (no) | Nye forbindelser | |
| NO20011262D0 (no) | Nye forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |